212650-45-8

Basic information

• Product Name: MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 3-METHYL ESTER
• Synonyms: MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 3-METHYL ESTER;4-t-Butyloxycarbonylmorpholine-3-carboxylicacid;Methyl 4-Boc-3-morpholinecarboxylate;3,4-Morpholinedicarboxylic acid, 4-(1,1-diMethylethyl) 3-Methyl ester;4-N-Boc-morpholine-3-carboxylic acid 3-methyl ester;4-O-tert-butyl 3-O-methyl morpholine-3,4-dicarboxylate;tert-butyl methyl morpholine-3,4-dicarboxylate
• CAS NO: 212650-45-8
• Molecular Formula: C11H19NO5
• Molecular Weight: 245.27
• Mol File: 212650-45-8.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 3-METHYL ESTER(CAS DataBase Reference)
• NIST Chemistry Reference: MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 3-METHYL ESTER(212650-45-8)
• EPA Substance Registry System: MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 3-METHYL ESTER(212650-45-8)

Safety Data

• Hazardous Substances Data: 212650-45-8(Hazardous Substances Data)

Usage

General Description

Morpholine-3,4-dicarboxylic acid 4-tert-butyl ester 3-methyl ester is a chemical compound with the molecular formula C14H23NO6. It is a derivative of morpholine, a widely used building block in organic synthesis. MORPHOLINE-3,4-DICARBOXYLIC ACID 4-TERT-BUTYL ESTER 3-METHYL ESTER is a colorless liquid with a molecular weight of 305.34 g/mol. It is commonly used as an intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. It has potential applications in the pharmaceutical industry as a building block for the synthesis of various drugs and biologically active compounds. Additionally, its tert-butyl and methyl ester groups make it a versatile compound for use in organic synthesis and chemical research.

InChI:InChI=1S/C10H17NO5/c1-10(2,3)16-9(14)11-4-5-15-6-7(11)8(12)13/h7H,4-6H2,1-3H3,(H,12,13)

Upstream product

• 212650-43-6 4-(tert-butoxycarbonyl)morpholine-3-carboxylic acid 
• 74-88-4 methyl iodide 
• 18107-18-1 diazomethyl-trimethyl-silane 
• 126264-49-1 methyl 3-morpholine-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 

Downstream Products

• 473923-56-7 tert-Butyl 3-(hydroxymethyl)-4-morpholinecarboxylate 
• 212650-43-6 4-(tert-butoxycarbonyl)morpholine-3-carboxylic acid 
• 1101987-05-6 N,N-dimethylmorpholine-3-carboxamide 
• 1447240-83-6 N-Boc-3-methylmorpholine-3-carboxylic acid methyl ester 

Relevant articles and documents

Tricyclic dihydroimidazopyrimidinone derivative, and preparation method, pharmaceutical composition and application thereof

The invention provides a compound as shown in a general formula (I), cis-trans isomers, enantiomers, diastereoisomers, racemes, solvates, hydrates or pharmaceutically acceptable salts or prodrugs of the compound, a preparation method of the compound, a pharmaceutical composition containing the compound and an application of the compound as aLp-PLA2 inhibitor, wherein R1, R2, Rx, Ra, Q, U, X, Y, m, n and A are defined in the specification.

ANTI-INFECTIVE COMPOUNDS

The present invention relates to small molecule compounds having the general formula (I): wherein A is a moiety selected from the group consisting of formulae (A) to (K) and their use in the treatment of bacterial infections, in particular Tuberculosis.

POLYHETEROCYCLIC COMPOUNDS AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS

The present invention relates to new compounds of formula (I), wherein P, Q, X1, X2, X3, X4, X5, X6, R1, R2, R3, m, n, and p are as defined as in formula (I), or salts, or hydrates thereof, processes for their preparation and new intermediates used in the preparation thereof, pharmaceutical compositions containing said compounds and to the use of said compounds in therapy.